These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 15585613)
1. Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization. Korshunov A; Sycheva R; Golanov A Clin Cancer Res; 2004 Dec; 10(23):7820-6. PubMed ID: 15585613 [TBL] [Abstract][Full Text] [Related]
2. Clinical utility of fluorescence in situ hybridization (FISH) in morphologically ambiguous gliomas with hybrid oligodendroglial/astrocytic features. Fuller CE; Schmidt RE; Roth KA; Burger PC; Scheithauer BW; Banerjee R; Trinkaus K; Lytle R; Perry A J Neuropathol Exp Neurol; 2003 Nov; 62(11):1118-28. PubMed ID: 14656070 [TBL] [Abstract][Full Text] [Related]
3. Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. Perry A; Fuller CE; Banerjee R; Brat DJ; Scheithauer BW Front Biosci; 2003 Jan; 8():a1-9. PubMed ID: 12456321 [TBL] [Abstract][Full Text] [Related]
5. Prognostic stratification of patients with anaplastic gliomas according to genetic profile. Dehais C; Laigle-Donadey F; Marie Y; Kujas M; Lejeune J; Benouaich-Amiel A; Pedretti M; Polivka M; Xuan KH; Thillet J; Delattre JY; Sanson M Cancer; 2006 Oct; 107(8):1891-7. PubMed ID: 16986124 [TBL] [Abstract][Full Text] [Related]
6. Assessment of 1p/19q deletions by fluorescence in situ hybridization in gliomas. Reddy KS Cancer Genet Cytogenet; 2008 Jul; 184(2):77-86. PubMed ID: 18617055 [TBL] [Abstract][Full Text] [Related]
7. Molecular diagnostic techniques for the clinical evaluation of gliomas. Kelley TW; Tubbs RR; Prayson RA Diagn Mol Pathol; 2005 Mar; 14(1):1-8. PubMed ID: 15714057 [TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of chromosomes 1 and 19 in glioma cell lines. Law ME; Templeton KL; Kitange G; Smith J; Misra A; Feuerstein BG; Jenkins RB Cancer Genet Cytogenet; 2005 Jul; 160(1):1-14. PubMed ID: 15949564 [TBL] [Abstract][Full Text] [Related]
9. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas. Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925 [TBL] [Abstract][Full Text] [Related]
10. Fluorescence in situ hybridization for 1p, 19q status in a cohort of glial neoplasms. Singh VY; Chacko G; Chacko AG; Rajshekhar V Neurol India; 2014; 62(1):32-6. PubMed ID: 24608451 [TBL] [Abstract][Full Text] [Related]
11. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. Pollack IF; Hamilton RL; James CD; Finkelstein SD; Burnham J; Yates AJ; Holmes EJ; Zhou T; Finlay JL; J Neurosurg; 2006 Nov; 105(5 Suppl):418-24. PubMed ID: 17328268 [TBL] [Abstract][Full Text] [Related]
12. BAC array CGH distinguishes mutually exclusive alterations that define clinicogenetic subtypes of gliomas. Idbaih A; Marie Y; Lucchesi C; Pierron G; Manié E; Raynal V; Mosseri V; Hoang-Xuan K; Kujas M; Brito I; Mokhtari K; Sanson M; Barillot E; Aurias A; Delattre JY; Delattre O Int J Cancer; 2008 Apr; 122(8):1778-86. PubMed ID: 18076069 [TBL] [Abstract][Full Text] [Related]
13. Chromogenic in situ hybridization is a reliable alternative to fluorescence in situ hybridization for diagnostic testing of 1p and 19q loss in paraffin-embedded gliomas. Lass U; Hartmann C; Capper D; Herold-Mende C; von Deimling A; Meiboom M; Mueller W Brain Pathol; 2013 May; 23(3):311-8. PubMed ID: 23107103 [TBL] [Abstract][Full Text] [Related]
14. Repeated molecular testing in gliomas: a retrospective study of 53 cases. Mahajan D; Prayson RA Am J Clin Pathol; 2009 Jul; 132(1):118-24. PubMed ID: 19864242 [TBL] [Abstract][Full Text] [Related]
15. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status. Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156 [TBL] [Abstract][Full Text] [Related]
16. High-throughput molecular profiling of high-grade astrocytomas: the utility of fluorescence in situ hybridization on tissue microarrays (TMA-FISH). Fuller CE; Wang H; Zhang W; Fuller GN; Perry A J Neuropathol Exp Neurol; 2002 Dec; 61(12):1078-84. PubMed ID: 12484570 [TBL] [Abstract][Full Text] [Related]
17. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179 [TBL] [Abstract][Full Text] [Related]
18. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related]
19. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018 [TBL] [Abstract][Full Text] [Related]